27 Jul 2015

Flatoril (Cleboprida / Simeticona) - España

ATC: A03FA
ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
PROPULSIVES
PROPULSIVES
Flatoril

Last Updated on 27 Jul 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Flatoril Indication

Flatoril 500 microgramos/200 mg Cápsulas duras
- Tratamiento sintomático de los trastornos funcionales de la motilidad gastrointestinal que cursan con flatulencia en adultos.
- Tratamiento preventivo del meteorismo en las exploraciones radiológicas del tubo digestivo en adultos.
- Tratamiento sintomático de náuseas y vómitos postoperatorios que cursan con flatulencia en adultos.


Flatoril 100 microgramos/ml + 40 mg/ml Emulsión oral
- Tratamiento sintomático de los trastornos funcionales de la motilidad gastrointestinal que cursan con flatulencia en adultos y adolescentes.
- Tratamiento preventivo del meteorismo en las exploraciones radiológicas del tubo digestivo en adultos y adolescentes.
- Tratamiento sintomático de náuseas y vómitos postoperatorios que cursan con flatulencia en adultos.

 

Flatoril Generic Name

Cleboprida / Simeticona

Type

POM

Summary Product Characteristics (SPCs) Links
Resumen de las Características del Producto - Flatoril (external site)

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Flatoril Marketing Information

Flatoril Generic Name
Cleboprida / Simeticona
Marketing Company
ALMIRALL, S.A.
Drug Type
POM
Date of Issue, Marketing Authority 01/07/1984

Related Drugs - Gastroenterology

Back to top